Business
Pergoveris (Merck) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
Key market opportunities for the Pergoveris market include increased adoption of IVF procedures and precision hormone therapies, expanded fertility tourism, and rising infertility awareness. Advances in recombinant hormone technologies and patient-friendly injectable formats further drive growth, particularly amid tariff impacts encouraging domestic biologic production.Dublin, May 07, 2026 (GLOBE NEWSWIRE) -- The "Pergoveris Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights &
About this update from Merck & Company, Inc.
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/LAb6sww2pvOwp1YOuMHMug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUw/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"Key market opportunities for the Pergoveris market include increased adoption of IVF procedures and precision hormone therapies, expanded fertility tourism, and rising infertility awareness. Advances in recombinant hormone technologies and patient-friendly injectable formats further drive growth, particularly amid tariff impacts encouraging domestic biologic production.","length":372,"tagName":"p"},{"type":"text","content":"Dublin, May 07, 2026 (GLOBE NEWSWIRE) -- The "Pergoveris Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.","length":210,"tagName":"p"},{"type":"text","content":"The Pergoveris market is experiencing significant growth, driven by a range of factors and trends. Historically, the market has benefited from a rise in the diagnosis of gonadotropin deficiencies, the expansion of assisted reproductive clinics, and improvements in IVF success rates. The introduction of recombinant hormone technologies and increased infertility awareness have further fueled growth.","length":400,"tagName":"p"},{"type":"text","content":"Moving forward, the demand for advanced IVF protocols and precision hormone therapies is expected to rise. The expansion of fertility tourism and patient-friendly injectable formats are also projected to contribute to market growth. Investment in reproductive biotechnology remains strong, alongside a growing focus on precision-controlled fertility treatments and hormone deficiency management.","length":395,"tagName":"p"},{"type":"text","content":"A major driver of market expansion is the increasing prevalence of infertility, influenced by factors such as delayed childbearing, lifestyle choices, and conditions like PCOS and endometriosis. Pergoveris plays a crucial role by stimulating ovarian function, aiding w...